The provisions of Article R. 1333-48 apply :
1° To new radiopharmaceutical medicinal products benefiting from a marketing authorisation or an early access authorisation or a compassionate access authorisation mentioned in Article L. 5121-12 and II of Article L. 5121-12-1 ;
2° New radioactive implantable medical devices where this is justified by radiation protection issues.